Skip to main content

Table 3 Adverse events reported during treatment

From: Microelimination of hepatitis C in patients with chronic hemolytic anemias: a single-center experience

Adverse event

Number (%)

No

16 (76.19%)

Dizziness

1 (4.76%)

Anorexia

1 (4.76%)

Sleepiness

1 (4.76%)

Menorrhagia

1 (4.76%)

Sickle cell crisis

1 (4.76%)

Decompensation

1 (4.76%)